Jae Sevelius, PhD

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
Address550 16th. Street
San Francisco CA 94158
Phone415-502-1000 ext. 14622
ORCID ORCID Icon0000-0002-8318-038X Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoPostdoctoral Research ScholarBehavioral Medicine
    University of MissouriPhDClinical Psychology
    University of OregonPre-doctoral internship, APA-accreditedCounseling and Testing Center
    University of MissouriM.A.Gender Studies
    University of FloridaBachelor of SciencePsychology
    University of California, San Francisco, CA2018Diversity, Equity, and Inclusion Champion Training
    Collapse Awards and Honors
    UCSF School of Medicine2020Genentech Midcareer Development Award
    American Psychological Association, Committee on Sexual Orientation and Gender Diversity2018Outstanding Achievement Award
    CREDITS - Center for Research, Excellence, and Diversity in Team Science2017Strengthening Team Science in California
    Gladstone Center for AIDS Research, UCSF2016Early Career Research Excellence Award - Behavioral Science
    CORO, UCSF2015UCSF CORO Faculty Leadership
    Center for AIDS Prevention Studies, UCSF2010Innovative Dissemination Award

    Collapse Overview 
    Collapse Overview
    I am a licensed clinical psychologist whose research focuses on the investigation of risk and protective factors in transgender and gender diverse communities and relationships between intersectional stigma, gender affirmation, and health-related behaviors and outcomes. Most recently, my research has focused on developing and testing peer-led interventions to promote sexual health and resilience among transgender people by addressing intersectional stigma among transgender women of color and those affected by HIV in the San Francisco Bay Area and in São Paulo, Brazil.

    I am Co-Director of the Center for AIDS Prevention Studies (CAPS), Co-Director of the CAPS Developmental Core, and PI and co-founder of the Center of Excellence for Transgender Health.

    Collapse Research 
    Collapse Research Activities and Funding
    Mentoring clinical investigators in patient-oriented research on substance use and HIV
    NIH K24DA051328Jul 15, 2020 - Jun 30, 2025
    Role: Principal Investigator
    Reducing Intersectional Stigma among High-Risk Women in Brazil to Promote Uptake of HIV Testing and PrEP
    NIH R01MH121308Aug 14, 2019 - May 31, 2024
    Role: Multi Principal Investigator (MPI: Lippman, Sheri)
    A couples-based approach to HIV prevention for transgender women and their male partners
    NIH R01MH115765Jul 15, 2018 - Apr 30, 2023
    Role: Multi-Principal Investigator
    Improving engagement in HIV care for high-risk women
    NIH R01MH106373Sep 8, 2015 - Jun 30, 2020
    Role: Principal Investigator
    Culturally relevant intervention development for incarcerated transgender women
    NIH R34DA038541Sep 15, 2014 - Aug 31, 2017
    Role: Principal Investigator
    SHEROES: Cuturally relevant sexual risk reduction among high-risk women
    NIH R34MH102109Sep 26, 2013 - Jun 30, 2016
    Role: Principal Investigator
    Culturally Relevant HIV Prevention for High-Risk Women
    NIH K08MH085566Jan 1, 2009 - Feb 28, 2014
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications
    Collapse Global Health
    Collapse Academic Senate

    Collapse Featured Content 
    Collapse Featured Videos
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Evidence for the Model of Gender Affirmation: The Role of Gender Affirmation and Healthcare Empowerment in Viral Suppression Among Transgender Women of Color Living with HIV. AIDS Behav. 2021 Jul; 25(Suppl 1):64-71. Sevelius J, Chakravarty D, Neilands TB, Keatley J, Shade SB, Johnson MO, Rebchook G, HRSA SPNS Transgender Women of Color Study Group . PMID: 31144131.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    2. "She is Like a Sister to Me." Gender-Affirming Services and Relationships are Key to the Implementation of HIV Care Engagement Interventions with Transgender Women of Color. AIDS Behav. 2021 Jul; 25(Suppl 1):72-83. Maiorana A, Sevelius J, Keatley J, Rebchook G. PMID: 31912274.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Considerations for the Design of Pre-exposure Prophylaxis (PrEP) Interventions for Women: Lessons Learned from the Implementation of a Novel PrEP Intervention. AIDS Behav. 2021 Jun 17. Walters SM, Platt J, Anakaraonye A, Golub SA, Cunningham CO, Norton BL, Sevelius JM, Blackstock OJ. PMID: 34138377.
      View in: PubMed   Mentions:    Fields:    
    4. Correlates of Engagement in HIV Care Among Transgender Women of Color in the United States of America. AIDS Behav. 2021 May 26. Sevelius JM, Xavier J, Chakravarty D, Keatley J, Shade S, Rebchook G, SPNS Transgender Women of Color Study Group . PMID: 34037930.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Call for Special Issue Papers: Transgender Health and Corrections. J Correct Health Care. 2021 Jun; 27(2):71-72. Sevelius J, Jackson A, Harzke AJ. PMID: 34232774.
      View in: PubMed   Mentions:    Fields:    
    6. A Pilot Study to Evaluate a Novel Pre-exposure Prophylaxis Peer Outreach and Navigation Intervention for Women at High Risk for HIV Infection. AIDS Behav. 2021 May; 25(5):1411-1422. Blackstock OJ, Platt J, Golub SA, Anakaraonye AR, Norton BL, Walters SM, Sevelius JM, Cunningham CO. PMID: 32748159.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    7. Implementation Strategies for Creating Inclusive, All-Women HIV Care Environments: Perspectives From Trans and Cis Women. Womens Health Issues. 2021 Apr 30. Auerbach JD, Moran L, Weber S, Watson C, Keatley J, Sevelius J. PMID: 33941451.
      View in: PubMed   Mentions:    Fields:    
    8. Measuring Satisfaction and Comfort with Gender Identity and Gender Expression among Transgender Women: Development and Validation of the Psychological Gender Affirmation Scale. Int J Environ Res Public Health. 2021 Mar 23; 18(6). Sevelius JM, Chakravarty D, Dilworth SE, Rebchook G, Neilands TB. PMID: 33806834.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Mental Health and Psychosocial Risk and Protective Factors Among Black and Latinx Transgender Youth Compared With Peers. JAMA Netw Open. 2021 03 01; 4(3):e213256. Vance SR, Boyer CB, Glidden DV, Sevelius J. PMID: 33769506.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Community Belonging and Attitudes Towards HIV Pre-Exposure Prophylaxis (PrEP) Among Transgender Women. AIDS Behav. 2021 Feb 11. D'Avanzo PA, Bass SB, Kelly PJ, Brajuha J, Gutierrez-Mock L, Sevelius J. PMID: 33575901.
      View in: PubMed   Mentions:    Fields:    
    11. Inclusion as illusion: erasing transgender women in research with MSM. J Int AIDS Soc. 2021 Jan; 24(1):e25661. Poteat TC, van der Merwe LLA, Sevelius J, Keatley J. PMID: 33496381.
      View in: PubMed   Mentions:    Fields:    
    12. Gender Affirmation through Correct Pronoun Usage: Development and Validation of the Transgender Women's Importance of Pronouns (TW-IP) Scale. Int J Environ Res Public Health. 2020 12 19; 17(24). Sevelius JM, Chakravarty D, Dilworth SE, Rebchook G, Neilands TB. PMID: 33352630.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Housing stability and transactional sex among Spanish-speaking and English-speaking transgender women. Annals of LGBTQ+ Public and Population Health. 2020. Sauceda, J.A., Santiago-Rodriguez, E.I., Zaragoza, G., Rivas, C.E., Venegas, L., Zamudio-Haas, S., Gutierrez-Mock, L., Bass, S.B., Sevelius, JM .
    14. Couples-based approach to HIV prevention for transgender women and their partners: study protocol for a randomised controlled trial testing the efficacy of the 'It Takes Two' intervention. BMJ Open. 2020 10 15; 10(10):e038723. Gamarel KE, Sevelius JM, Neilands TB, Kaplan RL, Johnson MO, Nemoto T, Darbes LA, Operario D. PMID: 33060086.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    15. Dr. Valentina Wasson: Questioning what we think we know about the foundations of psychedelic science. Journal of Psychedelic Studies. 2020. Williams, M. T., Bartlett, A., Michaels, T., Sevelius, J., & George, J. R. View Publication.
    16. What Sexual and Gender Minority People Want Researchers to Know About Sexual Orientation and Gender Identity Questions: A Qualitative Study. Arch Sex Behav. 2020 10; 49(7):2301-2318. Suen LW, Lunn MR, Katuzny K, Finn S, Duncan L, Sevelius J, Flentje A, Capriotti MR, Lubensky ME, Hunt C, Weber S, Bibbins-Domingo K, Obedin-Maliver J. PMID: 32875381.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    17. We Are All Women: Barriers and Facilitators to Inclusion of Transgender Women in HIV Treatment and Support Services Designed for Cisgender Women. AIDS Patient Care STDS. 2020 09; 34(9):392-398. Auerbach JD, Moran L, Watson C, Weber S, Keatley J, Sevelius J. PMID: 32813571.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. We Are All Women: Barriers and facilitators to inclusion of transgender women in HIV treatment and support services designed for cisgender women. AIDS Patient Care and STDs. 2020. Auerbach, J., Moran, L., Watson, C., Weber, S., Keatley, J., Sevelius, J. View Publication.
    19. HIV Testing and PrEP Use in a National Probability Sample of Sexually Active Transgender People in the United States. J Acquir Immune Defic Syndr. 2020 08 15; 84(5):437-442. Sevelius JM, Poteat T, Luhur WE, Reisner SL, Meyer IH. PMID: 32692101.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    20. Sex Hormone Therapy and Tenofovir Diphosphate Concentration in Dried Blood Spots: Primary Results of the iBrEATHe Study. Clin Infect Dis. 2020 Aug 08. Grant RM, Pellegrini M, Defechereux PA, Anderson PL, Yu M, Glidden DV, O'Neal J, Yager J, Bhasin S, Sevelius J, Deutsch MB. PMID: 32766890.
      View in: PubMed   Mentions: 3     Fields:    
    21. What sexual and gender minority people want researchers to know about sexual orientation and gender identity questions: a qualitative study. Archives of Sexual Behavior. 2020. Suen, L; Lunn, M; Katuzny, K; Finn, S; Duncan, L; Sevelius, J; Flentje, A; Capriotti, M; Lubensky, M; Hunt, C; Weber, S; Bibbins-Domingo, K; Obedin-Maliver, J. View Publication.
    22. Research with Marginalized Communities: Challenges to Continuity During the COVID-19 Pandemic. AIDS Behav. 2020 07; 24(7):2009-2012. Sevelius JM, Gutierrez-Mock L, Zamudio-Haas S, McCree B, Ngo A, Jackson A, Clynes C, Venegas L, Salinas A, Herrera C, Stein E, Operario D, Gamarel K. PMID: 32415617.
      View in: PubMed   Mentions: 8     Fields:    
    23. HIV Testing and PrEP Use in a National Probability Sample of Sexually Active Transgender People in the United States. . 2020 May 13. Sevelius JM, Poteat T, Luhur WE, Reisner SL, Meyer IH. PMID: 32427722.
      View in: PubMed   Mentions:
    24. Sheroes: Feasibility and Acceptability of a Community-Driven, Group-Level HIV Intervention Program for Transgender Women. AIDS Behav. 2020 May; 24(5):1551-1559. Sevelius JM, Neilands TB, Dilworth S, Castro D, Johnson MO. PMID: 31562572.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Translating research into practice to close the health disparity gap in the LGBTQIA+ community. Annals of Behavioral Medicine. 2020; (54):S451-S45. Wiklund, L. O., Anderson-Carpenter, K. D., Sevelius, J. M., Ching, T., & Buchanan, N. T. View Publication.
    26. Longitudinal cohort of HIV-negative transgender women of colour in New York City: protocol for the TURNNT ('Trying to Understand Relationships, Networks and Neighbourhoods among Transgender women of colour') study. BMJ Open. 2020 04 01; 10(4):e032876. Callander D, Schneider JA, Radix A, Chaix B, Scheinmann R, Love G, Smith J, Regan SD, Kawachi I, St James K, Ransome Y, Herrera C, Reisner SL, Doroshow C, Poteat T, Watson K, Bluebond-Langner R, Toussaint N, Garofalo R, Sevelius J, Duncan DT. PMID: 32241785.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    27. Identifying Opportunities for Collaboration Across the Social Sciences to Reach the 10-10-10: A Multilevel Approach. . 2019 12 01; 82 Suppl 2:S118-S123. Vincent W, Sevelius J, Lippman SA, Linnemayr S, Arnold EA. PMID: 31658198.
      View in: PubMed   Mentions:
    28. Relationship Stigma and HIV Risk Behavior Among Cisgender Men Partnered with Transgender Women: The Moderating Role of Sexual Identity. Arch Sex Behav. 2020 01; 49(1):175-184. Gamarel KE, Sevelius JM, Reisner SL, Richardson RL, Darbes LA, Nemoto T, Operario D. PMID: 31586272.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    29. "Some of us, we don't know where we're going to be tomorrow." Contextual factors affecting PrEP use and adherence among a diverse sample of transgender women in San Francisco. AIDS Care. 2020 05; 32(5):585-593. Cahill SR, Keatley J, Wade Taylor S, Sevelius J, Elsesser SA, Geffen SR, Wang T, Mayer KH. PMID: 31482726.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    30. Developing Correctional Policy, Practice, and Clinical Care Considerations for Incarcerated Transgender Patients Through Collaborative Stakeholder Engagement. J Correct Health Care. 2019 07; 25(3):277-286. Kendig NE, Cubitt A, Moss A, Sevelius J. PMID: 31242806.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    31. The Psychedelic Renaissance and the limitations of a White-dominant medical framework. Journal of Psychedelic Studies. 2019. George, J.R., Michaels, T.I., Sevelius, J.M., Williams, M. View Publication.
    32. Medical Mistrust and PrEP Perceptions Among Transgender Women: A Cluster Analysis. Behav Med. 2019 Apr-Jun; 45(2):143-152. D'Avanzo PA, Bass SB, Brajuha J, Gutierrez-Mock L, Ventriglia N, Wellington C, Sevelius J. PMID: 31343968.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    33. Psychedelic-Assisted Therapy with Transgender and Gender Diverse Individuals. Bulletin of the Multidisciplinary Association for Psychedelic Studies, Special Edition: Women & Psychedelics. 2019; 1(24):39-42. Sevelius, J.
    34. Optimising HIV programming for transgender women in Brazil. Cult Health Sex. 2019 05; 21(5):543-558. Sevelius J, Murray LR, Martinez Fernandes N, Veras MA, Grinsztejn B, Lippman SA. PMID: 30378463.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    35. Commitment, interpersonal stigma, and mental health in romantic relationships between transgender women and cisgender male partners. J Soc Pers Relat. 2019 Jul; 36(7):2180-2201. Gamarel KE, Sevelius JM, Reisner SL, Coats CS, Nemoto T, Operario D. PMID: 31086428.
      View in: PubMed   Mentions:
    36. From erasure to opportunity: a qualitative study of the experiences of transgender men around pregnancy and recommendations for providers. BMC Pregnancy Childbirth. 2017 Nov 08; 17(Suppl 2):332. Hoffkling A, Obedin-Maliver J, Sevelius J. PMID: 29143629.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    37. Challenges and opportunities for gender-affirming healthcare for transgender women in prison. Int J Prison Health. 2017 03 13; 13(1):32-40. Sevelius J, Jenness V. PMID: 28299969.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    38. Transgender Population Size in the United States: a Meta-Regression of Population-Based Probability Samples. Am J Public Health. 2017 Feb; 107(2):216. Meerwijk EL, Sevelius JM. PMID: 28075643.
      View in: PubMed   Mentions:
    39. The Transgender Women of Color Initiative: Implementing and Evaluating Innovative Interventions to Enhance Engagement and Retention in HIV Care. American Journal of Public Health. 2017. Rebchook G, Keatley J, Contreras R, Perloff J, Molano LF, Reback CJ, Ducheny K, Nemoto T, Lin R, Birnbaum J, Woods T, Xavier J; SPNS Transgender Women of Color Study Group.
    40. The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices. J Int AIDS Soc. 2016; 19(7(Suppl 6)):21105. Sevelius JM, Deutsch MB, Grant R. PMID: 27760683.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansPHPublic Health
    41. Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis. . 2016 08 15; 72 Suppl 3:S226-9. Grant RM, Sevelius JM, Guanira JV, Aguilar JV, Chariyalertsak S, Deutsch MB. PMID: 27429187.
      View in: PubMed   Mentions:
    42. Transgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practices. J Int AIDS Soc. 2016; 19(3 Suppl 2):20810. Radix A, Sevelius J, Deutsch MB. PMID: 27431475.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    43. PrEP adherence among trans women in Brazil-access needed for this key population - Authors' reply. Lancet HIV. 2016 05; 3(5):e200-1. Sevelius J, Deutsch MB, Glidden DV, Grant RM. PMID: 27126486.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    44. 'You should build yourself up as a whole product': Transgender female identity in Lima, Peru. Glob Public Health. 2016 Aug-Sep; 11(7-8):981-93. Pollock L, Silva-Santisteban A, Sevelius J, Salazar X. PMID: 27080150.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    45. Acceptability and Feasibility of HIV Self-Testing Among Transgender Women in San Francisco: A Mixed Methods Pilot Study. AIDS Behav. 2016 Apr; 20(4):928-38. Lippman SA, Moran L, Sevelius J, Castillo LS, Ventura A, Treves-Kagan S, Buchbinder S. PMID: 26511864.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansPHPublic Health
    46. Adult development and quality of life of transgender and gender nonconforming people. Curr Opin Endocrinol Diabetes Obes. 2016 Apr; 23(2):188-97. Bockting W, Coleman E, Deutsch MB, Guillamon A, Meyer I, Meyer W, Reisner S, Sevelius J, Ettner R. PMID: 26835800.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    47. Barriers to healthcare for transgender individuals. Curr Opin Endocrinol Diabetes Obes. 2016 Apr; 23(2):168-71. Safer JD, Coleman E, Feldman J, Garofalo R, Hembree W, Radix A, Sevelius J. PMID: 26910276.
      View in: PubMed   Mentions: 97     Fields:    Translation:Humans
    48. 'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health. 2016 Aug-Sep; 11(7-8):1060-75. Sevelius JM, Keatley J, Calma N, Arnold E. PMID: 26963756.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansPHPublic Health
    49. In the name of brevity: The problem with binary HIV risk categories. Glob Public Health. 2016 Aug-Sep; 11(7-8):824-34. Kaplan RL, Sevelius J, Ribeiro K. PMID: 26824592.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    50. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Lancet HIV. 2015 Dec; 2(12):e512-9. Deutsch MB, Glidden DV, Sevelius J, Keatley J, McMahan V, Guanira J, Kallas EG, Chariyalertsak S, Grant RM, iPrEx investigators . PMID: 26614965.
      View in: PubMed   Mentions: 87     Fields:    Translation:HumansPHPublic Health
    51. Syndemics and gender affirmation: HIV sexual risk in female-to-male trans masculine adults reporting sexual contact with cisgender males. Int J STD AIDS. 2016 10; 27(11):955-66. Reisner SL, White Hughto JM, Pardee D, Sevelius J. PMID: 26384946.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    52. Transgender men who experienced pregnancy after female-to-male gender transitioning. Obstet Gynecol. 2014 Dec; 124(6):1120-1127. Light AD, Obedin-Maliver J, Sevelius JM, Kerns JL. PMID: 25415163.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    53. Transgender Issues in HIV. HIV Specialist: Patient Care, Practice Management, and Professional Information for HIV Care Providers. American Academy of HIV Medicine. 2014. Sevelius, J.
    54. Becoming Janet Mock. [Review of the book Redefining realness: My path to womanhood, identity, love and so much more., by J. Mock]. PsychCRITIQUES. 2014; 51(59). Sevelius, J., Sa’id, A., Warri, V. View Publication.
    55. Collection of gender identity data using electronic medical records: survey of current end-user practices. J Assoc Nurses AIDS Care. 2014 Nov-Dec; 25(6):657-63. Deutsch MB, Keatley J, Sevelius J, Shade SB. PMID: 24880490.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    56. Correlates of antiretroviral adherence and viral load among transgender women living with HIV. AIDS Care. 2014; 26(8):976-82. Sevelius JM, Saberi P, Johnson MO. PMID: 24646419.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    57. Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med. 2014 Feb; 47(1):5-16. Sevelius JM, Patouhas E, Keatley JG, Johnson MO. PMID: 24317955.
      View in: PubMed   Mentions: 116     Fields:    Translation:Humans
    58. Racial/ethnic disparities in history of incarceration, experiences of victimization, and associated health indicators among transgender women in the U.S. Women Health. 2014; 54(8):750-67. Reisner SL, Bailey Z, Sevelius J. PMID: 25190135.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    59. Gender Affirmation: A Framework for Conceptualizing Risk Behavior among Transgender Women of Color. Sex Roles. 2013 Jun 01; 68(11-12):675-689. Sevelius JM. PMID: 23729971.
      View in: PubMed   Mentions:
    60. Transgender women of color: discrimination and depression symptoms. Ethn Inequal Health Soc Care. 2013; 6(4):121-136. Jefferson K, Neilands TB, Sevelius J. PMID: 25346778.
      View in: PubMed   Mentions:
    61. HIV Prevention in Transgender Persons. Encyclopedia of AIDS. 2012. Sevelius, J. & Johnson, M.O.
    62. Preliminary support for the construct of health care empowerment in the context of treatment for human immunodeficiency virus. Patient Prefer Adherence. 2012; 6:395-404. Johnson MO, Sevelius JM, Dilworth SE, Saberi P, Neilands TB. PMID: 22654510.
      View in: PubMed   Mentions:
    63. HIV/AIDS programming in the United States: considerations affecting transgender women and girls. Womens Health Issues. 2011 Nov; 21(6 Suppl):S278-82. Sevelius JM, Keatley J, Gutierrez-Mock L. PMID: 22055679.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansPHPublic Health
    64. Antiretroviral therapy adherence among transgender women living with HIV. J Assoc Nurses AIDS Care. 2010 May-Jun; 21(3):256-64. Sevelius JM, Carrico A, Johnson MO. PMID: 20347342.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    65. "There's no pamphlet for the kind of sex I have": HIV-related risk factors and protective behaviors among transgender men who have sex with nontransgender men. J Assoc Nurses AIDS Care. 2009 Sep-Oct; 20(5):398-410. Sevelius J. PMID: 19732698.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    66. Informing interventions: the importance of contextual factors in the prediction of sexual risk behaviors among transgender women. AIDS Educ Prev. 2009 Apr; 21(2):113-27. Sevelius JM, Reznick OG, Hart SL, Schwarcz S. PMID: 19397434.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    67. Student responsiveness to women's and gender studies classes: The importance of initial student attitudes and classroom relationships. NWSA Journal. 2008; 2(20):189-215. Stake, J.E., Sevelius, J.M., Hanly, S.
    68. Men who have sex with transgender women: challenges to category-based HIV prevention. AIDS Behav. 2008 Jan; 12(1):18-26. Operario D, Burton J, Underhill K, Sevelius J. PMID: 17705095.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    69. The effects of prior attitudes and attitude importance on attitude change and class impact in women’s and gender studies. Journal of Applied Social Psychology. 2003; (33):2341 – 2353. Sevelius, J.M. & Stake, J.E.
    Jae's Networks
    Concepts (166)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (29)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.0.0-839-g49dc76ac on PROFILES-PWEB01.

    Copyright © The Regents of the University of California